252 related articles for article (PubMed ID: 22337770)
1. Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, β-glucocerebrosidase.
Jović M; Kean MJ; Szentpetery Z; Polevoy G; Gingras AC; Brill JA; Balla T
Mol Biol Cell; 2012 Apr; 23(8):1533-45. PubMed ID: 22337770
[TBL] [Abstract][Full Text] [Related]
2. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
Reczek D; Schwake M; Schröder J; Hughes H; Blanz J; Jin X; Brondyk W; Van Patten S; Edmunds T; Saftig P
Cell; 2007 Nov; 131(4):770-83. PubMed ID: 18022370
[TBL] [Abstract][Full Text] [Related]
3. A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1.
Balla A; Tuymetova G; Tsiomenko A; Várnai P; Balla T
Mol Biol Cell; 2005 Mar; 16(3):1282-95. PubMed ID: 15635101
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2.
Zunke F; Andresen L; Wesseler S; Groth J; Arnold P; Rothaug M; Mazzulli JR; Krainc D; Blanz J; Saftig P; Schwake M
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3791-6. PubMed ID: 27001828
[TBL] [Abstract][Full Text] [Related]
5. The lipid kinase PI4KIIIβ preserves lysosomal identity.
Sridhar S; Patel B; Aphkhazava D; Macian F; Santambrogio L; Shields D; Cuervo AM
EMBO J; 2013 Feb; 32(3):324-39. PubMed ID: 23258225
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the phosphatidylinositol 4-kinases, PI4KIIα and PI4KIIIβ, on Akt activation and apoptosis.
Chu KM; Minogue S; Hsuan JJ; Waugh MG
Cell Death Dis; 2010; 1(12):e106. PubMed ID: 21218173
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor.
Minogue S; Waugh MG; De Matteis MA; Stephens DJ; Berditchevski F; Hsuan JJ
J Cell Sci; 2006 Feb; 119(Pt 3):571-81. PubMed ID: 16443754
[TBL] [Abstract][Full Text] [Related]
8. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
[TBL] [Abstract][Full Text] [Related]
9. Localization of active endogenous and exogenous β-glucocerebrosidase by correlative light-electron microscopy in human fibroblasts.
van Meel E; Bos E; van der Lienden MJC; Overkleeft HS; van Kasteren SI; Koster AJ; Aerts JMFG
Traffic; 2019 May; 20(5):346-356. PubMed ID: 30895685
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.
Gonzalez A; Valeiras M; Sidransky E; Tayebi N
Mol Genet Metab; 2014 Feb; 111(2):84-91. PubMed ID: 24389070
[TBL] [Abstract][Full Text] [Related]
11. Distinct Golgi populations of phosphatidylinositol 4-phosphate regulated by phosphatidylinositol 4-kinases.
Weixel KM; Blumental-Perry A; Watkins SC; Aridor M; Weisz OA
J Biol Chem; 2005 Mar; 280(11):10501-8. PubMed ID: 15634669
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 4-kinase IIα is palmitoylated by Golgi-localized palmitoyltransferases in cholesterol-dependent manner.
Lu D; Sun HQ; Wang H; Barylko B; Fukata Y; Fukata M; Albanesi JP; Yin HL
J Biol Chem; 2012 Jun; 287(26):21856-65. PubMed ID: 22535966
[TBL] [Abstract][Full Text] [Related]
13. Gaucher disease: forging a new path to the lysosome.
Griffiths GM
Cell; 2007 Nov; 131(4):647-9. PubMed ID: 18022357
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of lysosomal enzymes to the endocytic compartment in human cells using engineered extracellular vesicles.
Do MA; Levy D; Brown A; Marriott G; Lu B
Sci Rep; 2019 Nov; 9(1):17274. PubMed ID: 31754156
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 4-kinase IIα function at endosomes is regulated by the ubiquitin ligase Itch.
Mössinger J; Wieffer M; Krause E; Freund C; Gerth F; Krauss M; Haucke V
EMBO Rep; 2012 Dec; 13(12):1087-94. PubMed ID: 23146885
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
Wong YC; Krainc D
Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
[TBL] [Abstract][Full Text] [Related]
17. A shortcut to the lysosome: the mannose-6-phosphate-independent pathway.
Coutinho MF; Prata MJ; Alves S
Mol Genet Metab; 2012 Nov; 107(3):257-66. PubMed ID: 22884962
[TBL] [Abstract][Full Text] [Related]
18. VAMP associated proteins are required for autophagic and lysosomal degradation by promoting a PtdIns4P-mediated endosomal pathway.
Mao D; Lin G; Tepe B; Zuo Z; Tan KL; Senturk M; Zhang S; Arenkiel BR; Sardiello M; Bellen HJ
Autophagy; 2019 Jul; 15(7):1214-1233. PubMed ID: 30741620
[TBL] [Abstract][Full Text] [Related]
19. Relationship between phosphatidylinositol 4-phosphate synthesis, membrane organization, and lateral diffusion of PI4KIIalpha at the trans-Golgi network.
Minogue S; Chu KM; Westover EJ; Covey DF; Hsuan JJ; Waugh MG
J Lipid Res; 2010 Aug; 51(8):2314-24. PubMed ID: 20388919
[TBL] [Abstract][Full Text] [Related]
20. Oxysterol binding protein-dependent activation of sphingomyelin synthesis in the golgi apparatus requires phosphatidylinositol 4-kinase IIα.
Banerji S; Ngo M; Lane CF; Robinson CA; Minogue S; Ridgway ND
Mol Biol Cell; 2010 Dec; 21(23):4141-50. PubMed ID: 20881054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
